The New England Journal of Medicine
e-mail icon  FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |    Advanced Search
Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe
 
Correspondence
PreviousPrevious
Volume 345:466-467 August 9, 2001 Number 6
NextNext

Fluvoxamine for the Treatment of Anxiety Disorders in Children and Adolescents

Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

 Sign up for free e-toc
 

This Article
-Full Text
- PDF
-Purchase this article

Tools and Services
-Add to Personal Archive
-Add to Citation Manager
-Notify a Friend
-E-mail When Cited

More Information
-PubMed Citation
To the Editor: It is with concern that I read the article by the Research Unit on Pediatric Psychopharmacology Anxiety Study Group (April 26 issue)1 promoting the treatment of young children with potent psychotropic drugs, adding to the several million American children who are already taking such medications. The Surgeon General's 1999 report on mental health, which states that "approximately one in five children and adolescents experiences the signs and symptoms of a DSM-IV [Diagnostic and Statistical Manual of Mental Disorders, fourth edition, revised] disorder during the course of a year,"2 emphasizes that we have increasingly relabeled troublesome behavior . . . [Full Text of this Article]

References



HOME  |  SUBSCRIBE  |  SEARCH  |  CURRENT ISSUE  |  PAST ISSUES  |  COLLECTIONS  |  PRIVACY  |  HELP  |  beta.nejm.org

Comments and questions? Please contact us.

The New England Journal of Medicine is owned, published, and copyrighted © 2008 Massachusetts Medical Society. All rights reserved.